ALK and non-small cell lung carcinoma: Indeed, despite most data being in favor of upfront ablative radiotherapy in patients with driver gene alterations [32,33], the risk of long-term radiation-related neurological toxicity or radionecrosis after brain irradiation should be considered in the light of long-term survival in patients with ALK-positive NSCLC [34].